Gaush Meditech Ltd., together with its subsidiaries, researches and develops, produces, and sells ophthalmic medical devices in the People's Republic of China and internationally. The company operates through Proprietary Products, Distribution, Technical, and Others segments. Its ophthalmic medical devices are used for diagnosis, treatment, or surgeries, including vitreoretinal diseases, cataract, glaucoma, refractive surgery, ocular surface diseases, optometry, and pediatric ophthalmology. The Proprietary Products segment develops and produces surgical equipment and related supporting software, intra optical lens, and ophthalmic disease diagnosis and treatment equipment and related supporting consumables. The Distribution segment sells diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment, and related supporting consumables. The Technical segment provides warranty services, maintenance services, and after-sales services related consumables. The Others segment engages in the provision of equipment leasing and agent registration services; and licensing intellectual properties. The company sells its products directly and through distributors to public and private hospitals, and other customers. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

Gaush Meditech Ltd

温州医科大学附属眼视光医院 provides comprehensive and quality eye health medical services, including prevention, diagnosis, treatment, rehabilitation, and healthcare, self-described as following a path of intrinsic development by offering superior services where others may not.

温州医科大学附属眼视光医院

成都爱迪眼科医院 is a national level three eye hospital that focuses on various eye diseases and corrective procedures.

成都爱迪眼科医院

高视医疗集团 specializes in the research, production, sales, training, and technical services of ophthalmic medical devices, self-described as having over twenty years of experience in the ophthalmology field.

Metric
Company Name	Gaush Meditech Ltd	温州医科大学附属眼视光医院	成都爱迪眼科医院
Symbol	2.41K
MSH ID	COM:GAUSH	CN:WZEYE	COM:028AIDI
Market	STOCKS	PRIVATE	PRIVATE
Sector		Healthcare & Health Services	Healthcare & Health Services
Industry		Medical Services	Healthcare
Country	CN	CN	CN
Stage
Employee Count	869
Website	gaush.com	wzeye.cn	028aidi.com
LinkedIn			%E6%88%90%E9%83%BD%E7%88%B1%E8%BF%AA%E7%9C%BC%E7%A7%91%E5%8C%BB%E9%99%A2%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8
Founders

Metric
Market Cap	217.82M
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

2407

COM:GAUSH

高视医疗集团

Last Close

10.24

22/11 08:08

Market Cap

1.69B

Beta: -

Volume Today

816.40K

Avg: -

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue